ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,722Medicare Part D Prescriptions Filled, Including Refills

Rank: 320 out of 939

$416K Total Retail Price of All Prescriptions

Rank: 340 out of 939

450 Patients Receiving at Least One Drug in Part D
58%Patients 65 Years and Older
76% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Arkansas
Lower avg

Schedule Two
Controlled Substances

5% of this provider’s 450 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

26% of this provider’s 450 patients filled at least one prescription for a schedule three drug, compared to an average of 19%.

Risky Drugs to Seniors

4% of this provider’s 5,429 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 2%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 21%.

Prescription Price

$48 was the average price of a prescription from this provider, compared to $49 among peers.

Prescriptions per Patient

19 is the average number of prescriptions (including refills) per patient, compared to an average of 22.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Arkansas
HYDROCODONE-ACETAMINOPHEN 383 232 S3 1 1
SIMVASTATIN 381 281 2 2
AMLODIPINE BESYLATE 323 253 3 6
METFORMIN HCL 277 179 4 8
NEXIUM 213 103 5 18
LISINOPRIL 203 123 6 3
GABAPENTIN 195 98 7 11
LEVOTHYROXINE SODIUM 190 135 8 4
RANITIDINE HCL 189 115 9 35
PRAVASTATIN SODIUM 174 130 10 13
MELOXICAM 170 103 11 14
POTASSIUM CHLORIDE 169 134 12 9
ZOLPIDEM TARTRATE 164 64 13 20
FUROSEMIDE 159 112 14 7
OMEPRAZOLE 141 93 15 5
CRESTOR 120 76 16 34
HYDROCHLOROTHIAZIDE 115 69 17 12
NAPROXEN 110 55 18 72
TRAMADOL HCL 104 57 19 16
METHADONE HCL 101 17 S2 20 109
SERTRALINE HCL 99 74 21 24
WARFARIN SODIUM 97 68 22 17
METOPROLOL SUCCINATE 96 72 23 21
ROPINIROLE HCL 96 52 23 78
GLIMEPIRIDE 93 45 25 37
METOPROLOL TARTRATE 93 45 25 10
DONEPEZIL HCL 87 87 27 30
PROAIR HFA 86 53 28 41
ATORVASTATIN CALCIUM 83 54 29 22
ATENOLOL 73 61 30 19
TERAZOSIN HCL 70 38 31 114
CITALOPRAM HBR 69 41 32 15
PLAVIX 66 36 33 48
ALENDRONATE SODIUM 65 47 34 40
CLONIDINE HCL 65 47 34 39
TRAZODONE HCL 63 49 36 26
AMITRIPTYLINE HCL 63 57 R 36 38
OXYBUTYNIN CHLORIDE 62 31 38 125
PREMARIN 61 56 R 39 111
GLYBURIDE-METFORMIN HCL 61 54 R 39 98
ALLOPURINOL 60 55 41 31
DIOVAN 59 43 42 50
VENTOLIN HFA 58 26 43 80
AMLODIPINE BESYLATE-BENAZEPRIL 58 40 43 58
COMBIVENT 56 18 45 120
TRILIPIX 56 20 45 231
SPIRIVA 56 28 45 73
TAMSULOSIN HCL 51 30 48 27
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on Feb. 6, 2014.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.